{
    "clinical_study": {
        "@rank": "124430", 
        "arm_group": {
            "arm_group_label": "Stem cell", 
            "arm_group_type": "Experimental", 
            "description": "autologous bone marrow mononuclear cell transplantation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study was to study the effect of stem cell therapy on common symptoms in\n      patients with autism spectrum disorders"
        }, 
        "brief_title": "Stem Cell Therapy in Autism Spectrum Disorders", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Autism Spectrum Disorders", 
        "condition_browse": {
            "mesh_term": [
                "Autistic Disorder", 
                "Child Development Disorders, Pervasive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosed cases of any type of autism spectrum disorders\n\n          -  age above 6 months\n\n        Exclusion Criteria:\n\n          -  presence of acute infections such as Human immunodeficiency virus/Hepatitis B\n             Virus/Hepatitis C Virus\n\n          -  malignancies\n\n          -  bleeding tendencies\n\n          -  pneumonia\n\n          -  renal failure\n\n          -  severe liver dysfunction\n\n          -  severe anemia [Hemoglobin < 8]\n\n          -  any bone marrow disorder\n\n          -  space occupying lesion in brain\n\n          -  other acute medical conditions such as respiratory infection and pyrexia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974973", 
            "org_study_id": "NGBSI-02"
        }, 
        "intervention": [
            {
                "arm_group_label": "Stem cell", 
                "intervention_name": "Autologous bone marrow mononuclear cell transplantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Stem cell", 
                "intervention_name": "Autologous bone marrow mononuclear cell transplantation in patients with autism", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "autism spectrum disorders", 
            "stem cells"
        ], 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "contact": {
                "email": "alok276@gmail.com", 
                "last_name": "Alok K Sharma, M.S, M.Ch.", 
                "phone": "91-22-25281610"
            }, 
            "facility": {
                "address": {
                    "city": "Mumbai", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "400071"
                }, 
                "name": "Neurogen brain and spine institute"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "Open Label Study of Autologous Bone Marrow Mononuclear Cells in Autism Spectrum Disorders", 
        "overall_contact": {
            "email": "alok276@gmail.com", 
            "last_name": "Alok K Sharma, M.S, M.Ch", 
            "phone": "91-22-25281610"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Indian Council of Medical Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Improvement in the scales for Autism spectrum disorders", 
            "safety_issue": "No", 
            "time_frame": "Six months"
        }, 
        "reference": {
            "PMID": "19364066", 
            "citation": "Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH, Montenegro X, Gonzalez R, Silva F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008;17(12):1277-93."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974973"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Positron Emission Tomography- computed tomography to study change in brain metabolism", 
            "safety_issue": "No", 
            "time_frame": "six months"
        }, 
        "source": "Neurogen Brain and Spine Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Neurogen Brain and Spine Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2009", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}